Clinical Trial Update: Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update examining nivolumab in men with high-risk biochemically recurrent prostate cancer. The study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING